ENTERPRISE PRODUCTS PARTNERS L.P.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
EPD$37.13+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Statements of Consolidated Cash Flows
| For the Nine MonthsEnded September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities: | ||
| Net income | $4,216 | $4,337 |
| Reconciliation of net income to net cash flow provided by operating activities: | ||
| Depreciation and accretion | 1,561 | 1,479 |
| Amortization of intangible assets | 159 | 155 |
| Amortization of major maintenance costs for reaction-based plants | 49 | 42 |
| Other amortization expense | 170 | 169 |
| Impairment of assets other than goodwill | 38 | 51 |
| Equity in income of unconsolidated affiliates | (276) | (302) |
| Distributions received from unconsolidated affiliates attributable to earnings | 280 | 303 |
| Net losses (gains) attributable to asset sales and related matters | (13) | 5 |
| Deferred income tax expense (benefit) | (1) | 23 |
| Change in fair market value of derivative instruments | 24 | (11) |
| Non-cash expense related to long-term operating leases (see Note 17) | 82 | 68 |
| Net effect of changes in operating accounts (see Note 18) | (169) | (563) |
| Other operating activities | (7) | 1 |
| Net cash flow provided by operating activities | 6,113 | 5,757 |
| Investing activities: | ||
| Capital expenditures | (4,319) | (3,485) |
| Investments in unconsolidated affiliates | (1) | – |
| Distributions received from unconsolidated affiliates attributable to the return of capital | 56 | 64 |
| Proceeds from asset sales and other matters | 21 | 11 |
| Other investing activities | (13) | (23) |
| Net cash flow used in investing activities | (4,256) | (3,433) |
| Financing activities: | ||
| Borrowings under debt agreements | 71,034 | 52,456 |
| Repayments of debt | (69,349) | (49,271) |
| Debt issuance costs | (29) | (44) |
| Monetization of interest rate derivative instruments | 14 | (33) |
| Cash distributions paid to common unitholders (see Note 8) | (3,499) | (3,374) |
| Cash payments made in connection with distribution equivalent rights | (33) | (32) |
| Cash distributions paid to noncontrolling interests | (68) | (84) |
| Cash contributions from noncontrolling interests | 5 | 33 |
| Repurchase of common units under 2019 Buyback Program | (250) | (156) |
| Acquisition of noncontrolling interests | – | (400) |
| Other financing activities | (88) | (66) |
| Net cash flow used in financing activities | (2,263) | (971) |
| Net change in cash and cash equivalents, including restricted cash | (406) | 1,353 |
| Cash and cash equivalents, including restricted cash, at beginning of period | 838 | 320 |
| Cash and cash equivalents, including restricted cash, at end of period | $432 | $1,673 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.